Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss widen to $0.15 per share. The company has a $37 million backlog for 2027 and expects revenue between $65 million and $85 million. However, it forecasts a 12% to 20% revenue decline in Q4 compared to last year, reflecting ongoing challenges despite growth prospects.
Enovix's stock price on Pluang is currently at USD 1.63, down 9.70% as of Nov 13, 2026, 23:51 WIB, reflecting a sharp intraday decline. This contrasts with its market cap of $396.10 million, indicating significant investor interest despite the recent downgrade. The typical hold time of 11 days suggests relatively short-term trading activity among Pluang users.
